Diagnostic and therapeutic considerations on inherited platelet disorders in neonates and children

Klinische Padiatrie

Volumn 222, Issue 3, 2010, Pages 209-214

  Schlegel, N ^a   Bardet, V ^a   Kenet, G ^b   Muntean, W ^c   Zieger, B ^d   Nowak Gottl U ^e  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b The Amalia Biron Research Institute of Thrombosis and Hemostasis   (Israel)

^c UNIVERSITY OF GRAZ   (Austria)

^d UNIVERSITY OF FREIBURG   (Germany)

^e UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Children; Developmental hemostasis; Infants; Laboratory work up; Neonates; Platelet function disorders

Indexed keywords

ANTIFIBRINOLYTIC AGENT; DESMOPRESSIN; DUAL SPECIFICITY PHOSPHATASE 2; FIBRINOGEN; FIBRINOGEN RECEPTOR; GLYCOPROTEIN IB; HLA ANTIGEN; PADGEM PROTEIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

AUTOIMMUNE THROMBOCYTOPENIA; BERNARD SOULIER DISEASE; BLEEDING; BLOOD ANALYSIS; CHILD; CHILD HEALTH CARE; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DYSERYTHROPOIESIS; ELECTROLYTE DISTURBANCE; FLOW CYTOMETRY; FLUID RETENTION; FLUSHING; GIEMSA STAIN; GLANZMANN DISEASE; HUMAN; HYPONATREMIA; HYPOTENSION; INFANT; LABORATORY TEST; MAY HEGGLIN ANOMALY; MEDICAL DECISION MAKING; MEDICAL RESEARCH; NEWBORN CARE; REFERENCE VALUE; REVIEW; SEIZURE; SIDE EFFECT; THROMBOCYTE DISORDER; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS;

ANTIFIBRINOLYTIC AGENTS; BLOOD PLATELET DISORDERS; CHILD; DEAMINO ARGININE VASOPRESSIN; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; FACTOR VIIA; HEMORRHAGIC DISORDERS; HUMANS; INFANT; INFANT, NEWBORN; MOLECULAR MOTOR PROTEINS; MYOSIN HEAVY CHAINS; PARTIAL THROMBOPLASTIN TIME; PLATELET COUNT; PLATELET FUNCTION TESTS; PLATELET TRANSFUSION; RECOMBINANT PROTEINS; SYNDROME; THROMBOCYTOPENIA; VON WILLEBRAND DISEASES; VON WILLEBRAND FACTOR;

EID: 77953623536     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0030-1249065     Document Type: Review

References (22)

1. Arrondel C, Vodovar N, Knebelmann B, et al. Expression of the Nonmuscle Myosin Heavy Chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes. J Am Soc Nephrol 2002 13 63-74
2. Balduini CL, Iolascon A, Savoia A. Inherited thrombocytopenias: from genes to therapy. Haematologica 2002 87 860-880
3. Bolton-Maggs PHB, Chalmers EA, Collins OPW, et al. A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO. Br J Haematol 2006 135 603-633
4. Coppola A, Di Minno G. Desmopressin in inherited disorders of platelet function. Haemophilia 2008 14 S1 31-33
5. Federici AB, Canciani MT. Clinical and laboratory versus molecular markers for a correct classification of von Willebrand disease. Haematologica 2009 94 610-615
6. Fujita H, Hashimoto Y, Russell S, et al. In vivo expression of murine platelet glycoprotein Ibalpha. Blood 1998 92 488-495
7. Hézard N, Potron G, Schlegel N, et al. Unexpected persistence of platelet hyporeactivity beyond the neonatal period: a flow cytometric study in neonates, infants and older children. Thromb Haemost 2003 90 116-123
8. Hurtaud-Roux MF, Hezard N, Lefranc V, et al. Quantification of the major integrins and P-Selectin in neonatal platelets by flow cytometry. A bicentric study. Thromb Haemost 2001 ISSN 0340-6245
9. Kühne T, Ryan G, Blanchette V, et al. Platelet-surface glycoproteins in healthy and preeclamptic mothers and their newborn infants. Pediatr Res 1996 40 876-880
10. Kunishima S, Matsushita T, Kojima T, et al. Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leucocyte inclusions. J Hum Genet 2001 46 722-729
11. Michelson AD, Rajasekhar D, Bednarek FJ, et al. Platelet and platelet-derived microparticle surface factor V/Va binding in whole blood: differences between neonates and adults. Thromb Haemost 2000 84 689-694
12. Nurden AT, Nurden P, Bermejo E, et al. Phenotypic heterogeneity in the Gray Platelet Syndrome extends to the expression of TREM family member, TLT-1. Thromb Haemost 2008 100 45-51
13. Nurden AT, Fiore M, Pillois X, et al. Genetic testing in the diagnostic evaluation of inherited platelet disorders. Sem Thromb Hemost 2009 35 204-212
14. Rajasekhar D, Kestin AS, Bednarek FJ, et al. Neonatal platelets are less reactive than adult platelets to physiological agonists in whole blood. Thromb Haemost 1994 72 957-963
15. Rajasekhar D, Barnard MR, Bednarek FJ, et al. Platelet hyporeactivity in very low birth weight neonates. Thromb Haemost 1997 77 1002-1007
16. Rolf N, Knoefler R, Bugert P, et al. Clinical and laboratory phenotypes associated with the aspirin-like defect: a study in 17 unrelated families. Br J Haematol 2008 144 416-424
17. Scharf RE. Erworbene Plättchenfunktionsstörungen. Pathogenese, Klassifikation, Häufigkeit, Diagnostik und Behandlung. Haemostaseologie 2008 28 299-311
18. Seri M, Cusano R, Gangarossa S, et al. Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Hegglin/Fechtner Syndrome Consortium. Nat Genet 2000 26 103-105
19. Zieger B, Jenny A, Tsakiris DA, et al. A large Swiss family with Bernard-Soulier syndrome Correlation phenotype and genotype. Haemostaseologie 2009 29 161-167
20. Kosch A, Kehrel B, Nowak-Göttl U, et al. Thrombocytic alpha-delta-storage-pool-disease: shortening of bleeding time after infusion of 1-desamino-8-D-arginine vasopressin. Klin Pädiatr 1999 211 198-200
21. Poon MC, DOrion R, von Depka M, et al. Prophylactic and therapeutic recombinant factor VIIa administration to Glanzmann's thrombasthenia: results of an international survey. J Thromb Haemost 2004 2 1093-1103
22. Almeida KM, Khair K, Hann I, et al. The use of recombinant factor VIIa in children with inherited platelet function disorders. Br J Haematol 2003 121 477-481